C-(4-Methyl-1-piperidin-1-yl-cyclohexyl)-methylamine
|
- $378 - $796.95
- Product name: C-(4-Methyl-1-piperidin-1-yl-cyclohexyl)-methylamine
- CAS: 927992-14-1
- MF: C13H26N2
- MW: 210.36
- EINECS:
- MDL Number:MFCD08667805
- Synonyms:C-(4-Methyl-1-piperidin-1-yl-cyclohexyl)-methylamine;(4-methyl-1-piperidin-1-ylcyclohexyl)methanamine;(4-methyl-1-piperidin-1-yl-cyclohexyl)methanamine;(4-methyl-1-piperidino-cyclohexyl)methylamine;[4-methyl-1-(1-piperidyl)cyclohexyl]methanamine;Cyclohexanemethanamine, 4-methyl-1-(1-piperidinyl)-
3 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 500MG
- 1g
- ManufacturerAK Scientific
- Product number3459AF
- Product descriptionC-(4-Methyl-1-piperidin-1-yl-cyclohexyl)-methylamine
- Packaging1g
- Price$560
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0140368
- Product descriptionC-(4-METHYL-1-PIPERIDIN-1-YL-CYCLOHEXYL)-METHYLAMINE 95.00%
- Packaging500MG
- Price$796.95
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number034244
- Product descriptionC-(4-Methyl-1-piperidin-1-yl-cyclohexyl)-methylamine
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 3459AF | C-(4-Methyl-1-piperidin-1-yl-cyclohexyl)-methylamine | 1g | $560 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CHM0140368 | C-(4-METHYL-1-PIPERIDIN-1-YL-CYCLOHEXYL)-METHYLAMINE 95.00% | 500MG | $796.95 | 2021-12-16 | Buy |
| Matrix Scientific | 034244 | C-(4-Methyl-1-piperidin-1-yl-cyclohexyl)-methylamine | 1g | $378 | 2021-12-16 | Buy |
Properties
Boiling point :258.9±8.0 °C(Predicted)
Density :0.952±0.06 g/cm3(Predicted)
pka :10.27±0.29(Predicted)
Density :0.952±0.06 g/cm3(Predicted)
pka :10.27±0.29(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|